Phytochemicals Target Multiple Metabolic Pathways in Cancer.

Shuvalov, Oleg; Kirdeeva, Yulia; Daks, Alexandra; Fedorova, Olga; Parfenyev, Sergey; Simon, Hans-Uwe; Barlev, Nickolai A (2023). Phytochemicals Target Multiple Metabolic Pathways in Cancer. Antioxidants, 12(11) MDPI 10.3390/antiox12112012

[img]
Preview
Text
antioxidants-12-02012.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (15MB) | Preview

Cancer metabolic reprogramming is a complex process that provides malignant cells with selective advantages to grow and propagate in the hostile environment created by the immune surveillance of the human organism. This process underpins cancer proliferation, invasion, antioxidant defense, and resistance to anticancer immunity and therapeutics. Perhaps not surprisingly, metabolic rewiring is considered to be one of the "Hallmarks of cancer". Notably, this process often comprises various complementary and overlapping pathways. Today, it is well known that highly selective inhibition of only one of the pathways in a tumor cell often leads to a limited response and, subsequently, to the emergence of resistance. Therefore, to increase the overall effectiveness of antitumor drugs, it is advisable to use multitarget agents that can simultaneously suppress several key processes in the tumor cell. This review is focused on a group of plant-derived natural compounds that simultaneously target different pathways of cancer-associated metabolism, including aerobic glycolysis, respiration, glutaminolysis, one-carbon metabolism, de novo lipogenesis, and β-oxidation of fatty acids. We discuss only those compounds that display inhibitory activity against several metabolic pathways as well as a number of important signaling pathways in cancer. Information about their pharmacokinetics in animals and humans is also presented. Taken together, a number of known plant-derived compounds may target multiple metabolic and signaling pathways in various malignancies, something that bears great potential for the further improvement of antineoplastic therapy.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology

UniBE Contributor:

Simon, Hans-Uwe

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2076-3921

Publisher:

MDPI

Language:

English

Submitter:

Pubmed Import

Date Deposited:

28 Nov 2023 13:56

Last Modified:

28 Nov 2023 14:06

Publisher DOI:

10.3390/antiox12112012

PubMed ID:

38001865

Uncontrolled Keywords:

cancer metabolism glutaminolysis glycolysis lipid metabolism metabolic reprogramming and plasticity multitarget agents natural compounds one-carbon metabolism β-oxidation of fatty acids

BORIS DOI:

10.48350/189422

URI:

https://boris.unibe.ch/id/eprint/189422

Actions (login required)

Edit item Edit item
Provide Feedback